ACE and AGTR1 genes polymorphisms in left ventricular hypertrophy pathogenesis in humans

Molekulyarnaya Biologiya

Volumn 38, Issue 6, 2004, Pages 990-996

  Makeeva, O A ^a   Puzyrev, K V ^b   Pavlukova, E N ^b   Koshelskaya, O A ^b   Golubenko, M V ^a   Efimova, E V ^b   Kucher, A N ^a   Tsymbaliuk, I V ^c   Karpov, R S ^b   Puzyrev, V P ^a,c  

^a RESEARCH INSTITUTE OF MEDICAL GENETICS   (Russian Federation)

^b CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^c SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

3' UNTRANSLATED REGIONS; ALLELES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 21644434644     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Levy D., Garrison R.J., Savage D.D. et al. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566.
2. Swynghedauw B. 1999. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79, 215-262.
3. Rigat B., Hubbert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene according for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346.
4. Crisan D., Carr J. 2000. Angiotensin I-converting enzyme: genotype and disease associations. J. Mol. Diagn. 2, 105-115.
5. Angerholm-Larsen B., Nordestgaard B.G., Tybjærg-Hansen A. 2002. ACE gene polymorphism in cardiovascular disease. Meta-analyses of small and large studies in whites. Arterioscler. Thromb. Vasc. Biol. 20, 484-492.
6. Villard E., Tiret L., Visvikis S., Rakotovao R., Cambien F., Soubrier F. 1996. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am. J. Hum. Genet. 58, 1268-1278.
7. Zhu X., Bouzekri N., Southam L., Cooper R. S. et. al. 2001. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am. J. Hum. Genet. 68, 1139-1148.
8. Devereux R.B., Richec N. 1977. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55, 613-618.
9. Hildick-Smith D.J.R., Shapiro L.M. 2001. Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy. Heart. 85, 615-619.
10. Keavney B., McKenzie C., Connell J.M.C., Julier C., Ratcliffe P.J., Sobel E., Lathrop M., Farrall M. 1998. Measured haplotype analysis of the angiotensin-1 converting enzyme (ACE) gene. Hum. Mol. Genet. 7, 1745-1751.
11. Takemoto Y., Sakatani M., Takami S. et al. 1998. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax. 53, 459-462.
12. Kehoe P. G., Katzov H., Feuk L. et al. 2003. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum. Mol. Genet. 12, 859-867.
13. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., Arveiler D., Luc G., Kee F., Ducimetiere P., Soubrier F., Cambien F. 1994. Synergistic effect of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 344, 910-913.
14. Bonnardeaux A., Davis E., Jeiunemaitre X. et al. 1994. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension. 24, 63-69.
15. Hingorani A.D., Jia H., Stevens P.A. et al. 1995. Reninangiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J. Hypertens. 13, 1602-1609.
16. Amant C., Hamon M., Bauters C. et al. 1997. The angiotensin II typel receptor gene polymorphism is associated with coronary artery vasoconstriction. J. Am. Coll. Cardiol. 29, 486-490.
17. Osterop A.P.R.M., Kofflard M.J.M., Sandkuijl L.A. et al. 1998. ATI Receptor A/Cl 166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension. 32, 825-830.
18. van Geel P.P., Pinto Y.M., Buikema H., van Gilst W.H. 1998. Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease? Eur. Heart J. 19 (Suppl. G), G13-7.
19. Kuznetsova T., Staessen J.A., Wang J.G., Gasowski J., Nikitin Y., Ryabikov A., Fagard R. 2000. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J. Hum. Hypert. 14, 447-454.